Research

Mixed

Electronic health record (EHR) data from the one-year period prior to initiating anti-obesity medication (AOM) contains sufficient multidimensional clinical signals to identify distinct obesity subtypes (clusters) with unique physiological profiles, enabling precision medicine approaches that outperform traditional BMI-based classifications.

If you are considering obesity medication, ask your doctor about 'deep phenotyping.' This means using your full medical history (labs, vitals, diagnoses) from the past year to group you into a specific 'obesity subtype.' This helps predict which medication will work best for you, rather than just using your BMI. It reduces the guesswork in choosing between different drugs like GLP-1 agonists or others.

GoodSupportsHIGH confidence
Our analysis revealed the presence of clusters with distinct clinical significance, which could have implications in AOM treatment options.
Xiaoyang Ruan et al. · Journal of Medical Internet Research · 2025

Why this rating

Large cohort (32,969 patients), rigorous ML methodology (GRU-D-AE, GMM), reproducible clustering, but observational and proof-of-concept.

Source

Deep Phenotyping of Obesity: Electronic Health Record–Based Temporal Modeling Study

Xiaoyang Ruan et al. · Journal of Medical Internet Research · 2025

DOI 10.2196/70140

cohort · n=32969Cited 2×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →